Retatrutide-Specific Safety Signals Dysaesthesia is the most notable new finding abnormal skin sensations including tingling, burning, numbness, or unusual sensitivity to touch
SUD patients, have also ask for the integration of PREM items in the survey and more specific questions regarding their health status
[00:29:00] We have to protect our muscle mass
The FDA has received adverse-event reports involving compounded semaglutide and tirzepatide, including dosing errors and events requiring medical attention
Retatrutide 20mg is supplied in lyophilized format and is intended exclusively for laboratory research and analytical use
Retrieved March 10, 2026, from 16 For the majority of the period depicted in Figure 2, chronic weight management was the sole approved indication for Wegovy, Zepbound, and Saxenda